ArticleMicroorganisms2021
Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 68 citations in OpenAlex.
- An EndophyticJournal of fungi (Basel, Switzerland) · 2026Article
- Multifunctional Bioactivity ofCurrent issues in molecular biology · 2026Article
- Bacillus velezensis Bac-9, isolated from kefir, possesses antifungal activity and improves resistance of tomato plant against whitefly Bemisia tabaci.BMC microbiology · 2025Article
- Identification and Genomic Insights into the Biological Control and Growth-Promoting Mechanism ofMicroorganisms · 2025Article
- Bacterial Cyclic Lipopeptides as Triggers of Plant Immunity and Systemic Resistance Against Pathogens.Plants (Basel, Switzerland) · 2025Review
- Effects of Magnaporthe oryzae cell-free filtrate on the secondary metabolism of Streptomyces bikiniensis HD-087: a non-targeted metabolomics analysis.Microbial cell factories · 2025Article
- Pectin-derived oligogalacturonides shape mutualistic interactions between Bacillus and its host plant.The ISME journal · 2025Article
- Prospection for potential new non-ribosomal peptide gene clusters inFrontiers in microbiology · 2025Article
- Genomic and metabolomic insights into the biocontrol potential ofFrontiers in microbiology · 2025Article
- Isolation, identification, and whole-genome sequencing of Streptomyces rochei FE-3-1 against Pyricularia oryzae.PloS one · 2025Article
- Bacillus velezensis BE2 controls wheat and barley diseases by direct antagonism and induced systemic resistance.Applied microbiology and biotechnology · 2024Article
- Antagonistic StrainInternational journal of molecular sciences · 2024Article
- Bacillus velezensis: a versatile ally in the battle against phytopathogens-insights and prospects.Applied microbiology and biotechnology · 2024Review
- Broad-Spectrum Efficacy and Modes of Action of TwoJournal of fungi (Basel, Switzerland) · 2024Article
- Lipopeptides from Bacillus: unveiling biotechnological prospects-sources, properties, and diverse applications.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Review
- Transplantation of soil from organic field confers disease suppressive ability to conducive soil.World journal of microbiology & biotechnology · 2024Article
- Review
- Biological control potential of worrisome wheat blast disease by the seed endophytic bacilli.Frontiers in microbiology · 2024Article
- Co-Culture of White Rot FungiJournal of fungi (Basel, Switzerland) · 2023Article
- Tissue-Specific Hormone Signalling and Defence Gene Induction in an In Vitro Assembly of the RapeseedInternational journal of molecular sciences · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
Abstract
Rice monoculture in acid sulfate soils (ASSs) is affected by a wide range of abiotic and biotic constraints, including rice blast caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.